Skip to main content
. 2017 Mar 6;3:17005. doi: 10.1038/cddiscovery.2017.5

Table 1. Melanoma biomarkers utilized for detection of CMCs.

Melanoma Biomarkers References
Tyrosinase (Tyr-OH) Smith et al.73; Hoon et al.74; Curry et al.75; Brownbridge et al.95
Melan A/MART 1 Hoon et al.74; Curry et al.75; Tsukamoto et al.77; Schittek et al.83; Brownbridge et al.95
MCAM/MUC18/CD146 Hoon et al.74; Curry et al.75; Lehmann et al.98; Melnikova and Bar-Eli 99
MAGE 3 Hoon et al.74; Curry et al.75; Gaugler et al.76
P97/Melanotransferin/MFI2 Rose et al.80; Hoon et al.74; Curry et al.75
TRP-1/TRP-2 Jiménez-Cervantes et al.91; Sarantou et al.93
B4GALNT1 (beta-1,4-N acetyl-galactosaminyl transferase 1) Kuo et al.86; Sarantou et al.93
MCSP (melanoma chondroitin sulphate proteoglycan) Yang et al.88
ABCB5 (ATP-binding cassette transporter 5) Schatton and Frank32; Frank et al.96; Venditelli et al.97
CD 271 (neural crest nerve growth factor receptor) Boiko et al.113; Luo et al.115